{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:18:27Z","timestamp":1780478307730,"version":"3.54.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2000,5,9]]},"DOI":"10.1212\/wnl.54.9.1726","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:46:12Z","timestamp":1336916772000},"page":"1726-1733","source":"Crossref","is-referenced-by-count":134,"title":["Linomide in relapsing and secondary progressive MS"],"prefix":"10.1212","volume":"54","author":[{"given":"J.H.","family":"Noseworthy","sequence":"first","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Wolinsky","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.D.","family":"Lublin","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Whitaker","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Linde","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gjorstrup","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"From the Department of NeurologyMayo Clinic\/Mayo Foundation, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the North American Linomide Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780291115"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00399792"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.5.5997"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90009-4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00051-9"},{"key":"e_1_3_2_7_2","first-page":"56","volume":"115","year":"1999","unstructured":"Zhu J, Bai XF, Hedlund G, et al. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses. Clin Exp Immunol 1999;115:56\u201363.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00023-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340506"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4444"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00115-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.14.6400"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00244-5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(87)90016-6"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(96)00211-1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.134.6.3956"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.142.9.3225"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.10.1603"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230949"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(96)00197-X"},{"key":"e_1_3_2_21_2","first-page":"94","volume":"98","year":"1998","unstructured":"Tian WZ, Navikas V, Matusevicius D, et al. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis. Acta Neurol Scand 1998;98:94\u2013101.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00371-1"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(98)00070-4"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118908"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1997.d01-155.x"},{"key":"e_1_3_2_26_2","first-page":"1499","volume":"55","year":"1995","unstructured":"Vukanovic J, Isaacs JT. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res 1995;55:1499\u20131504.","journal-title":"Cancer Res"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(199609)29:3<183::AID-PROS4>3.0.CO;2-F"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15718.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.186"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.4.895"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.2.341"},{"key":"e_1_3_2_32_2","first-page":"A174.","volume":"48","year":"1997","unstructured":"Hohol M, Guttmann M, Cook S, et al. Roquinimex (linomide) treatment in secondary progressive and relapsing remitting multiple sclerosis: results from 48 week randomized, double-blind, placebo-controlled pilot studies. Neurology 1997;48:A174. Abstract.","journal-title":"Neurology"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.907"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390104"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1342"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245859500100107"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.54.9.1726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:08:49Z","timestamp":1711537729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.54.9.1726"}},"subtitle":["Part I: Trial design and clinical results"],"short-title":[],"issued":{"date-parts":[[2000,5,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,5,9]]}},"alternative-id":["10.1212\/WNL.54.9.1726"],"URL":"https:\/\/doi.org\/10.1212\/wnl.54.9.1726","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5,9]]}}}